Ipamorelin + CJC-1295 Stack: Evidence, Mechanism, and Protocol At a glance Drug class / Growth hormone secretagogue (GHRP) + Growth hormone-releasing hormone analogue (GHRH analogue) Ipamorelin receptor target / Ghrelin receptor (GHSR-1a), selective, no cortisol or prolactin spike CJC-1295 receptor target / GHRH receptor (GHRHR) on pituitary somatotrophs Combination mechanism / GHRP + GHRH co-stimulation raises GH pulse amplitude 2-to-10-fold over either agent alone in animal models Typical ipamorelin dose / 100-300 mcg subcutaneous injection, 1-3x daily Typical CJC-1295 (no DAC) dose / 100-300 mcg subcutaneous injection, timed with ipamorelin Typical CJC-1295 with DAC dose / 1,000-2,000 mcg subcutaneous injection, once weekly Primary evidence level / Mechanistic + animal + one Phase II RCT (CJC-1295)
There is evidence suggesting that L-Carnitine may increase the frequency of seizures in susceptible individuals
SeethalerBBasraiMNeyrinckAMNazareJAWalterJDelzenneNMet al
How are peptide protocols personalized
IV vitamin therapy delivers essential nutrients directly into your bloodstream for fast, effective absorptionmaking it ideal for boosting energy, improving hydration, enhancing recovery, and supporting immune function
The TB-500 protocol is one of the tools we use to address those injuries at the biological level rather than managing symptoms while the clock runs out